A comparative study of platelet-rich plasma, hydroxyapatite, demineralized bone matrix and autologous bone to promote bone regeneration after mandibular impacted third molar extraction 
Introduction
The study of materials to promote bone regeneration is a key issue in oral surgery. The autologous bone is still considered as the gold standard (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Autologous bone grafts have a number of advantages such as their potential osteogenic, osteoinductive and osteoconductor properties, the absence of rejection and disease transmission. Furthermore, autologous bone grafts do not require sophisticated and expensive techniques to obtain them (6) . However a number of disadvantages were described: morbidity in the donor site, the need for general anesthesia or sedation, as well as the occasional need for more than one surgical field. In addition, graft survival is unpredictable, its resorption cannot be foretold and availability is limited (6) . It is for the reason that in recent years several biocompatible materials have emerged as substitutes of autologous bone. These can be classified into two major groups: organic and synthetic. Biological biomaterials can be allogeneic or homologous (human cortical bone and demineralised bone matrix or demineralized freeze-dried), heterologous, or xenogeneic (organic bovine, porcine, caprine, coral-derived hydroxyapatite) and replicating (morphogenetic proteins). Among synthetic biomaterials we can find artificial or synthetic hydroxyapatite, the bioglass and bioceramics (6) . In addition, over the last 20 years a large number of publications advocating the use of platelet-rich plasma (PRP) in oral surgery have been published. There is evidence and consensus on its utility in the regeneration of soft and periodontal tissues (1) (2) (3) (4) (11) (12) (13) . On the other hand, there are plenty of publications that show that there is not enough scientific evidence to support the use of PRP in accelerating bone healing. Therefore there are many biomaterials available for the oral surgeon´s use to promote bone healing. But the exact indication of each of them remains controversial. There is no therapeutic consensus algorithm, and there are few clinical trials with sufficient statistical power (6, 14) . Our hypothesis is that the PRP and other biomaterials such as calcium hidroxipatita synthetic and demineralized bone matrix can replace autologous grafts in promoting bone regeneration in mandibular bone defects. Objectives To determine the role and usefulness of the PRP and other biomaterials (synthetic calcium hydroxyapatite and allogenic, demineralized bone matrix) in mandibular bone regeneration compared with autologous bone (gold standard). We use as a model an easily reproducible non-critical bone defect: the defect that remains after extraction of mandibular impacted third molar. Therefore, the aim of this study was to try to answer the following questions:
• Are there differences in the rate of bone formation in the postextraction socket among those grafted with PRP and controls (not grafted)?
• Are there differences in the neoformation of bone between the two different procedures to obtain plateletrich plasma (PRP)?
• Which biomaterial accelerates more bone regeneration in non-critical mandibular bone defect ?
• Are there significant differences between them with each other and with respect to autologous bone in the acceleration of bone neoformation?
• Are there differences in the clinical inflammatory and postoperative (postoperative pain, intraoral-extraoral swelling, trismus) and infectious events observed depending on the material used to graft the socket? Inclusion criteria. To carry out this study we selected 82 patients with bilateral impacted mandibular third molars, ftaking into account the following inclusion criteria:
Material and Methods
• Aged between 18 and 50 years old.
• Impacted mandibular third molar 3.8. and 4.8, with a similar anatomical position, and similar surgical difficulty.
• The patient signed the informed consent to carry out the intervention and for inclusion in the study.
• No allergies to medicines prescribed in the postoperative period.
• To follow the same postoperative treatment: Amoxicillin 500 mg every 8 hours during 7 days, deflazacort 30 mg every 12 hours for 5 days and metamizol 575 mg every 8 hours to demand. Study groups. The patients were divided into 5 groups (Table 1 ). In two groups (groups 1 and 2) we compared the control socket (no biomaterial) with the study socket (platelet-rich plasma). These two groups differ in the methodology used in obtaining the PRP (methods 1 and 2 respectively ). In groups 3, 4 and 5, we administered PRP obtained by the same method (Method 1) on the control side, compared with the study side in which we administered a combination of PRP with another product:
• Autologous bone obtained from aspiration and filtering during the osteotomy (group 3).
• A synthetic material based on synthetic calcium hydroxyapatite (Novabone ® Porex Surgical Inc, MTF, USA) (group 4).
• Allogeneic demineralized bone matrix (DBX ®, Synthes, USA) (group 5). Surgery. Extractions of both mandibular third molars was performed under local anesthesia. All extractions were performed by the same surgeon. Both post-extraction sockets were grafted with different biomaterials, according to the distribution of the study groups ( Fig.  1 ). All patients received the same antibiotic, anti-inflammatory and analgesic postoperative treatment. Monitoring and variables. (Fig. 2) . The studied pre- We assessed several response variables on the postoperative evolution in two ways. On the one hand, through a clinical questionnaire that each patient completed daily throughout the first postoperative week. This questionnaire asssesed pain (using two methods: an analog pain scale from 1 to 10 points, and the number of analgesics to control pain consumed on each of the first 7 postoperative days) as well as the number of days that passed until the restart of a normal diet. On the other hand, a single clinical observer performed a clinical assessment in the 7th postoperative day. This observer assessed the most inflamed side, decreased mouth opening measured in mm compared to that observed at the time of the intervention, and the occurrence of infectious events. This clinical observer was blinded for whether or not socket grafting was performed, and the type of grafted material. In this appointment, the questionnaire mentioned above was collected.
In addition we compared the bone formation on both sides using digital panoramic obtained in the immediate postoperative period, at the 3 and in 6 months after the surgery. The measurement of bone neoformation was performed subjectively but blindly, recording the score in a radiopaque increasing scale (1, minimal or radiopaque bone formation 5, maximum or radiopaque bone formation) by 4 blinded observers, who were staff surgeons of the research team. A process of calibration between the different observers took place before to assess the degree of concordance. The observers were blinded as to the type of material used for grafting the postextraction socket. Although this material is partially radiopaque (such as calcium hydroxyapatite), this radiopacity is not considered formed bone. For an expert observer (as the ones in the study) it is not difficult to differentiate between the neoformation of bone and the radiopacity produced by the existence of a biomaterial. In addition, due to resorption of the grafted material, there is no possibility of bias in the assessment at 6 and 3 months. CT and bone biopsy were excluded for economic and ethical reasons. 
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Results
Of the 82 patients included in the study 37 were males and 45 were females. The median age of patients in our study is 23 years, with a minimum of 18 years and maximum of 45 years (mean: 24.16; typical dev: 5.76). The distribution of study groups according to the material used is as shown in (Table 1) . We observed a greater degree of surgical difficulty in the extraction in group 3 (autologous bone) and 5 (DBX® ) on the control side as well as on the study side. In what refers to the pain recorded by patients on the pain analogue scale from 1 to 10, we observed more pain on the study side, although no significant differences between groups were found. However, it an increased use of analgesics in groups 1, 2 and 3 (PRP and bone) compared to groups 4 and 5 (Novabone® and DBX®) with no statistically significant differences between groups was observed. The study groups with more days of dysphagia were 4 and 3 (Novabone® and bone).
Concerning the clinical variables observed on the 7th postoperative day by a blinded clinical observer, we can say that in most cases, both the control and study sides were equally swollen, although there is a greater tendency to inflammation in the study side. There were no statistically significant differences between the studied groups. There is also no statistically significant differences in the incidence of infectious events among the study side and the control side. Intraoral inflammation observed on the 7th postoperative day was higher in group 3 (bone) and 5 (DBX®), although both groups have the greater surgical difficulty, wich could cause a bias. On 7th postoperative day, the greatest percentage of patients with extraoral inflammation belong to group 3 (bone) and 2 (PRP 2). We considered trismus as an oral opening less than 35 mm. The greater percentage of patients with trismus on 7th postoperative day was observed in the gropus 3 (bone) and 4 (Novabone®). The groups with less patient with trismus were the groups 5 (DBX®) and 1 (PRP method 1).
In what regards bone formation, bone gain observed at 3rd postoperative month compared to the immediate postoperative period was higher in groups 1, 2 and 3 (PRP and autologous bone) and lower in groups 4 and 5 (DBX® and Novabone® ). Bone formation observed at 6th postoperative month, with respect to 3rd postoperative month is higher in groups 3 (autologous bone) and 5 (DBX® ) (p=0,049). The lowest increment was found in groups Novabone® and PRP groups. There is a progressive ossification of the surgical site in all study groups except Novabone® (p=0.0045). The greatest bone formation at 6th postoperative month is observed in group 3 (autologous bone), followed by group 5 (DBX ®). The greatest bone gain at 6 months compared to the immediate postoperative period was observed in group 3 (autologous bone) followed by group 5 (DBX ®) (Fig. 3) . 
Discussion
The platelet-rich plasma (PRP) is defined as a high concentration of autologous platelets in a small volume of autologous plasma (1,2). These intact platelets contained in this concentrate of autologous plasma would release their alpha granules in the first minutes after their activation. These alpha granules contain molecules such as PDGF, TGFB, IGF, and other angiogenic factors that stimulate proliferation, chemotaxis and differentiation of cells essential to osteogenesis. These molecules could accelerate a process that occurs by itself (it does not cre-ate a new process). Throughout the past 20 years, PRP has been widely used in many medical applications (to speed up the healing process of burns, chronic ulcers, in the repair knee ligaments, as an hemostatic, to promote retinal neurogenesis, etc.). There are many randomized clinical trials that have established PRP usefulness in the field of soft tissue regeneration. The first article that quotes the use of PRP in oral surgery was published in 1997 by Whitman et al. (3) It states that through the activation of platelets in the platelet gel, and the subsequent release of growth factors, we could expect the acceleration of surgical wound healing (3) . Perhaps the most outstanding paper in what refers to platelet-rich plasma in the field of oral and maxillofacial surgery was published by Marx in 1998 (4), who performed 88 autologous bone grafts in human jaws, to half of which these authors added PRP. Marx et al. (4) gathered both radiographic and histomorphometric studies showed greater maturation and bone density, statistically significant compared to the control group. There are several publications for the use of PRP in oral surgery. There is evidence and consensus on its utility in the regeneration of soft tissue and periodontal defects (1-4, 11,12,14) . On the contrary there are also plenty of publications that show that nowadays there is not enough scientific evidence to support the use of PRP in accelerating bone healing, and insist that the oral surgeon must take a critical and analytical attitude ( (8) found evidence of beneficial effects of PRP in the treatment of periodontal defects but the evidence of beneficial effects in sinus lift seems to be weak. They concluded that considering the literature review in their article conclusions about other applications of PRP in dentistry cannot be drawn. In our study we didn't observe further acceleration in bone formation at 6 months, either in cases in which PRP was used alone nor in those cases where PRP was mixed with autologous bone or other biomaterials. We didn't find differences between the two different methods of obtaining PRP. Like Thor et al. (9) we found that PRP facilitates and accelerates bone formation in the beginning of the bone healing (the three first months in the postoperative period). This effect is not already observed at the 6th month. So like other authors, we can not support the indication of the use of PRP in this type of bone defect because there is no acceleration of bone healing. We agree with other authors that there is a better healing of soft tissue and increased handling of the graft. Demineralised bone matrix (DBX®, Synthes, USA) is a suitable substitute for cancellous bone. It presents osteoinductive and osteoconductive properties. These properties are known experimentally since the work of Urist in the 70s (16) (17) (18) (19) . DBX consists in demineralised bone to which an organic carrier is added (sodium hyaluronate). It is extracted from human cortical bone, by removing the mineral phase and preserving the collagen and morphogenetic proteins (BMPs). Removing the mineral phase enhances the bioavailability of these morphogenetic proteins, which would promote the bone neoformation (17) . There is a lot of literature supporting its use as an accelerator of the bone healing. This biomaterial presents multiple applications in oral and craniomaxillofacial surgery (16) (17) (18) (19) . We have noticed that demineralised bone matrix accelerates significantly bone formation in the studied defect. Synthetic calcium hydroxyapatite (Novabone granules, Porex Surgical, Inc, MTF, USA) is a synthetic, particulate and inorganic bone. It is biocompatible and resorbable in 6 months (bioglass) and it also presents osteoconductive activity (13, 20) . We have not observed any benefit in its use to accelerate bone formation in the post-extraction socket.
Conclusions
The faster bone formation occurred in the groups where we used autologous bone and demineralized bone matrix, respectively. Autologous bone remains as the gold standard of materials used to optimize the mandibular bone regeneration. Among the biomaterials compared in the study, demineralized bone matrix is the second most effective in bone neoformation. We have not observed in our study that the platelet-rich plasma accelerates bone formation in post-extraction sockets. Platelet-rich plasma mixed with other biomaterials facilitates the manipulation of the graft (made of hydroxyapatite, for example) and therefore could be useful as a biological carrier in mandibular bone reconstruction due to its low cost and ready availability. There were no statistically significant differences between groups in postoperative follow up. Finally, it is important to emphasize the difficulty observed in selecting an appropriate method to objectively quantify bone formation. Further studies, with larger number of cases and controls, are necessaries to assess bone neoformation with biomaterials used in this study (as well as other biomaterials) to establish conclusive results.
